Xeris Pharmaceuticals Announces FDA Acceptance for Review of NDA for Its Ready-to-Use Glucagon Rescue Pen

Stock Information for Xeris Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.